Hvivo scores £13.1m contract to test influenza B vaccine
Hvivo will conduct a study to find an influenza B dose that creates a safe infection, before launching a human challenge trial next year.
Source: siliconrepublic.com
Stay updated with breaking news from Mo Khan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hvivo will conduct a study to find an influenza B dose that creates a safe infection, before launching a human challenge trial next year.
HVIVO secures first client of the new human metapneumovirus (hMPV) model
(via NewsDirect) <iframe src=
HVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Thomas Warner from Proactive after announcing that the specialist contract research organisation has...
Pharmaceutical services firm Hvivo, formerly Open Orphan, will pay a dividend to shareholders after a “record financial and operational performance” last year.